- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Institut Cancerologie de l'Ouest
Total 346 results
-
Institut de Cancérologie de la LoireCompleted
-
Institut de Cancérologie de la LoireTerminatedElderly Patients | Systemic Treatment | Metastatic NeoplasiaFrance
-
Institut de Cancérologie de la LoireCompleted
-
Institut de Cancérologie de la LoireUnknown
-
Institut de Cancérologie de la LoireCompleted
-
Institut de Cancérologie de la LoireCompleted
-
Institut de Cancérologie de la LoireCompleted
-
Institut de cancérologie Strasbourg EuropeNot yet recruiting
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Institut de cancérologie Strasbourg EuropeNot yet recruiting
-
Institut de cancérologie Strasbourg EuropeRecruitingNeoplasms | Digestive System DiseaseFrance
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Institut de cancérologie Strasbourg EuropeCompletedVaginal Cancer | Prostate Carcinoma | Radiotherapy | Rectum Carcinoma | Cervix Carcinoma | Anal Canal Carcinoma | Endometrium CarcinomaFrance
-
Institut de cancérologie Strasbourg EuropeCompletedHematologic Malignancy | Tumor, SolidFrance
-
Instituto Nacional de Cancerologia de MexicoCompletedNon-Small Cell Lung Cancer | EGFR | HER-2Mexico
-
Instituto Nacional de Cancerologia de MexicoCompletedCarcinoma, Non-Small-Cell Lung | Synchronous NeoplasmsMexico
-
Instituto Nacional de Cancerologia de MexicoCompletedPromyelocytic Leukemia, AcuteMexico
-
Instituto Nacional de Cancerologia de MexicoCompletedPhase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRIMexico
-
Instituto Nacional de Cancerologia de MexicoCompletedNon Small-cell Lung CancerMexico
-
Instituto Nacional de Cancerologia de MexicoUnknownEGFR Gene Mutation | Tyrosine Kinase Mutation | Non-Small Cell AdenocarcinomaMexico
-
Instituto Nacional de Cancerologia de MexicoUnknownNon-Small Cell Lung CancerMexico
-
Institut de Cancérologie de LorraineVitadxRecruiting
-
Institut de Cancérologie de LorraineClinactCompleted
-
Institut de Cancérologie de la LoireCompleted
-
Institut de Cancérologie de la LoireCompletedNon-Small-Cell Lung CarcinomaFrance
-
Institut de Cancérologie de la LoireCompletedHealthy | Breast CancerFrance
-
Institut de cancérologie Strasbourg EuropeRecruitingLymphoma | Leukemia, Myeloid, AcuteFrance
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingHER2-positive Breast Cancer
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Institut de cancérologie Strasbourg EuropeCompleted
-
Institut de cancérologie Strasbourg EuropeCompleted
-
Institut de cancérologie Strasbourg EuropeCompleted
-
Instituto Nacional de Cancerologia de MexicoRecruitingHematologic Neoplasms | NeutropeniaMexico
-
Instituto Nacional de Cancerologia de MexicoRecruitingNon-Small Cell Lung Cancer With EGFR MutationMexico
-
Instituto Nacional de Cancerologia de MexicoCompletedMajor Depressive Disorder | Advanced CancerMexico
-
Instituto Nacional de Cancerologia de MexicoCompletedLung Cancer | Skin RashMexico
-
Instituto Nacional de Cancerologia de MexicoUnknownQuality of Life | Breast Neoplasm | Antineoplastic Agents | AntiemeticsMexico
-
Instituto Nacional de Cancerologia de MexicoUnknown
-
Instituto Nacional de Cancerologia de MexicoCompleted
-
Instituto Nacional de Cancerologia de MexicoUnknownAnorexia | Non-Small Cell Lung Cancer | Cachexia | Weight LoseMexico
-
Instituto Nacional de Cancerologia, ColumbiaCompletedUterine Cervical Neoplasms
-
Institut de cancérologie Strasbourg EuropeNot yet recruiting
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Institut de cancérologie Strasbourg EuropeRecruitingGlioma | Brain MetastasesFrance
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingProtocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)HER2-positive Breast Cancer
-
Institut de cancérologie Strasbourg EuropeWithdrawnHematologic Malignancy | COVID19France
-
Instituto Nacional de Cancerologia de MexicoRecruitingNon-small Cell Lung Cancer | Brain Metastases | EGFR Gene MutationMexico